PL318534A1 - (azetydin-1-nylalkyl)lactams as antagonists of tachykinins - Google Patents

(azetydin-1-nylalkyl)lactams as antagonists of tachykinins

Info

Publication number
PL318534A1
PL318534A1 PL95318534A PL31853495A PL318534A1 PL 318534 A1 PL318534 A1 PL 318534A1 PL 95318534 A PL95318534 A PL 95318534A PL 31853495 A PL31853495 A PL 31853495A PL 318534 A1 PL318534 A1 PL 318534A1
Authority
PL
Poland
Prior art keywords
azetydin
nylalkyl
tachykinins
lactams
antagonists
Prior art date
Application number
PL95318534A
Other versions
PL183180B1 (en
Inventor
Alexander Roderick Mackenzie
Alan Patrick Marchington
Sandra Dora Meadows
Donald Stuart Middleton
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Priority claimed from PCT/EP1995/003054 external-priority patent/WO1996005193A1/en
Publication of PL318534A1 publication Critical patent/PL318534A1/en
Publication of PL183180B1 publication Critical patent/PL183180B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL95318534A 1994-08-09 1995-07-29 (azetydin-1-nylalkyl)lactams as antagonists of tachykinins PL183180B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9416084A GB9416084D0 (en) 1994-08-09 1994-08-09 Lactams
PCT/EP1995/003054 WO1996005193A1 (en) 1994-08-09 1995-07-29 (azetidin-1-ylalkyl)lactams as tachykinin antagonists

Publications (2)

Publication Number Publication Date
PL318534A1 true PL318534A1 (en) 1997-06-23
PL183180B1 PL183180B1 (en) 2002-05-31

Family

ID=10759627

Family Applications (1)

Application Number Title Priority Date Filing Date
PL95318534A PL183180B1 (en) 1994-08-09 1995-07-29 (azetydin-1-nylalkyl)lactams as antagonists of tachykinins

Country Status (5)

Country Link
KR (1) KR100218626B1 (en)
CO (1) CO4410338A1 (en)
GB (2) GB9416084D0 (en)
PE (1) PE34696A1 (en)
PL (1) PL183180B1 (en)

Also Published As

Publication number Publication date
PL183180B1 (en) 2002-05-31
PE34696A1 (en) 1996-10-01
CO4410338A1 (en) 1997-01-09
KR100218626B1 (en) 1999-09-01
GB9416084D0 (en) 1994-09-28
KR970704729A (en) 1997-09-06
GB9417898D0 (en) 1994-10-26

Similar Documents

Publication Publication Date Title
HU9603082D0 (en) Neurokinine (tachykinine) antagonists
HUT74808A (en) Gnrh antagonists
SG64884A1 (en) Bicyclic fibrinogen antagonists
AU7947594A (en) Substituted amides as tachykinin antagonists
AU1842995A (en) N-acylpiperidine tachykinin antagonists
AU4343796A (en) Tachykinin antagonists
EP0810994A4 (en) Fibrinogen receptor antagonists
EP0866705A4 (en) Fibrinogen receptor antagonists
EP0796098A4 (en) Fibrinogen receptor antagonists
HU9601176D0 (en) Adhesion-receptor antagonists
PL338004A1 (en) Derivatives of azetidinylpropylpiperidine, intermediate compounds and application of such derivatives as antagonists of tachykinins
NZ324712A (en) 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists
ZA956869B (en) Novel N-substituted naphthofused lactams
EP0796252A4 (en) Bicyclic fibrinogen antagonists
HU9503191D0 (en) Adhesion-receptor antagonists
IL129121A0 (en) N-substituted azaheterocyclic compounds
PL333079A1 (en) Piparazinic derivatives as antagonists of neurokinin
EP0794779A4 (en) Fibrinogen receptor antagonists
ZA9711238B (en) Preparation of N-substituted 3-hydroxypyrozoles
ZA98256B (en) Tachykinin antagonists
GB9515852D0 (en) Fibrinogen receptor antagonists
AU1574995A (en) Tachykinins antagonists
GB9705861D0 (en) Trypthophan ureas as neurokinin antagonists
PL318534A1 (en) (azetydin-1-nylalkyl)lactams as antagonists of tachykinins
PL340544A1 (en) Substituted oximes as antagonists of neurokinin